Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts.
Lab research · 2017
- What was studied
- NIH/3T3 mouse fibroblasts, including CD44-knockout cells
- Main finding
- The defined TEKKRRETVEREKE peptide promoted differentiation-related changes through ERK1/2 signaling without SMAD activation.
Study data at a glance
- Participants or experimental model
- NIH/3T3 mouse fibroblasts, including CD44-knockout cells
- Reported results
- The defined TEKKRRETVEREKE peptide promoted differentiation-related changes through ERK1/2 signaling without SMAD activation.
Study limitations and source details
Study limitations
- Cell signaling does not quantify wound healing in patients.
- Full methods, reporting completeness and independent replication remain to be appraised.
Source details
Original journal report
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Abstract reviewed
Sources checked
Citation
Chulkina M, Negmadjanov U, Lebedeva E, Pichugin A, Mazurov D, Ataullakhanov R, Holmuhamedov E. Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts. European journal of pharmacology · PMID 28668507
Study source ↗ · DOI 10.1016/j.ejphar.2017.06.033 · Bibliography entry · Link to this summary